DARE - Dare Bioscience Inc
IEX Last Trade
3.56
0.010 0.281%
Share volume: 60,938
Last Updated: Fri 30 Aug 2024 09:31:08 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$3.55
0.01
0.28%
Fundamental analysis
23%
Profitability
25%
Dept financing
17%
Liquidity
50%
Performance
15%
Performance
5 Days
0.85%
1 Month
4.68%
3 Months
-30.72%
6 Months
-40.78%
1 Year
-57.98%
2 Year
-72.38%
Key data
Stock price
$3.56
DAY RANGE
N/A - N/A
52 WEEK RANGE
$3.05 - $8.40
52 WEEK CHANGE
-$0.56
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/07/2024
Company detail
CEO:
Region: US
Website: darebioscience.com
Employees: 26
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: darebioscience.com
Employees: 26
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
daré bioscience (nasdaq: dare) is a clinical-stage biopharmaceutical company committed to the advancement of innovative products for women’s reproductive health. we are driven by a mission to identify, develop and bring to market a diverse portfolio of novel therapies that expand treatment options, improve outcomes and facilitate convenience for women. we are initially focused on the areas of contraception, vaginal health and fertility. our lead product candidate, ovaprene, is a non-hormonal, monthly contraceptive ring that is currently in clinical studies.
Recent news